Skip to main content

JANE STREET GROUP, LLC

Position in JANX — Janux Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in JANX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$3,499,185
-$3,956,029 QoQ
Shares Held
251,740
-53.4% QoQ
Ownership
0.413%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JANX Over Time

Shares Held

Position Value (USD)

Derivatives in JANX

reported options exposure · as of Mar 31, 2026
CallValue
$803,420
CallShares
57,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. JANX ranks #58 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JANX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,499,185 251,740
2026-03-31 $803,420 57,800
2025-12-31 $7,455,214 540,233
2025-12-31 $335,340 24,300
2025-12-31 $828,000 60,000
2025-09-30 $1,987,508 81,322
2025-09-30 $290,836 11,900
2025-06-30 $249,480 10,800
2025-06-30 $781,079 33,813
2025-03-31 $834,300 30,900
2024-12-31 $219,514 4,100
2024-12-31 $204,201 3,814
2024-12-31 $2,687,708 50,200
2024-09-30 $436,128 9,600
2024-09-30 $1,778,947 39,158
2024-06-30 $1,657,418 39,566
2024-03-31 $757,968 20,132
2023-06-30 $177,278 14,935
2021-12-31 $310,668 15,746